In head and neck cancer, the DNMT1 inhibitor 5‐aza‐CdR inhibits ferroptosis by the epigenetic reprogramming of EMT,65 which provides a therapeutic approach for therapy‐resistant cancer. This evidence concerns the gene DNMT1 and head and neck cancer.